SCHEMBL22075550

SCHEMBL22075550

CCCCCCCCCCCCCCCC(=O)Oc1ccc2c(CCC)cc(=O)oc2c1C.CCCc1cc(=O)oc2c(C)c(O)ccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.54
▸ HPGD P15428 6/20 0.54
▸ ALDH1A1 P00352 5/20 0.54
▸ GLA P06280 4/20 0.54
▸ KMT2A Q03164 6/20 0.53
▸ GAA P10253 3/20 0.53
▸ HSD17B10 Q99714 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ RXFP1 Q9HBX9 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ CASP1 P29466 1/20 0.47
▸ CASP7 P55210 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ HIF1A Q16665 1/20 0.45
▸ POLB P06746 1/20 0.45
▸ ERAP1 Q9NZ08 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22075534 0.95 KDM4E (0.58) KDM4EHPGDALDH1A1GLAKMT2A
SCHEMBL15984890 0.82 KDM4E (0.64) KDM4EHPGDALDH1A1GLAKMT2A
SCHEMBL18074001 0.81 KDM4E (0.62) KDM4EHPGDALDH1A1GLAKMT2A
SCHEMBL18073970 0.79 KDM4E (0.55) KDM4EHPGDALDH1A1GLAKMT2A
SCHEMBL15295521 0.71 MCL1 (0.70) KDM4EHPGDALDH1A1GLAKMT2A
SCHEMBL31454860 0.71 ALDH1A1 (0.58) KDM4EHPGDALDH1A1GLAKMT2A
SCHEMBL6559997 0.70 GAA (0.71) KDM4EHPGDALDH1A1GLAKMT2A
SCHEMBL10144071 0.70 KDM4E (0.60) KDM4EHPGDALDH1A1KMT2AGAA
SCHEMBL14756277 0.70 ALDH1A1 (0.57) KDM4EHPGDALDH1A1GLAKMT2A
SCHEMBL31454895 0.70 ALDH1A1 (0.48) KDM4EHPGDALDH1A1GLAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200190050-A1 LYSOSOMAL ACID LIPASE ASSAY UNIVERSITY OF WASHINGTON (US) 2020-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190050-A1 LYSOSOMAL ACID LIPASE ASSAY LIPA, LPL, PNLIP KDM4E 4408/4885HPGD 1589/4885ALDH1A1 1095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback